Reduction of the taxable amount – Agreement between pharmaceutical company and health insurer
Is a national rule under which a pharmaceutical undertaking which makes payments to a public health insurer on the basis of turnover from the sale of medicinal products under a voluntary agreement is not entitled to reduce the taxable amount retrospectively contrary to Article 90(1) of the Directive?
Unofficial translation. More information/source documents expected later.
